Adjunct use of Novoseven&#174; (recombinant factor VIIa) for penetrating cardiac trauma

Luis Manuel García-Núñez; Luis Enrique Soto-Ortega; Ruy Cabello-Pasini; Luis Enrique Payró-Hernández; Ignacio Javier Magaña-Sánchez

2008, Number 1

<< Back

Cir Cir 2008; 76 (1)

Adjunct use of Novoseven® (recombinant factor VIIa) for penetrating cardiac trauma

García-Núñez LM, Soto-Ortega LE, Cabello-Pasini R, Payró-Hernández LE, Magaña-Sánchez IJ

Full text

How to cite this article

Language: Spanish
References: 0
Page: 95-98
PDF size: 66.50 Kb.

ABSTRACT

Background: Uncontrolled bleeding leads to 40-86% of preventable deaths due to trauma. Use of NovoSeven (rFVIIa) in trauma is promising, although data supporting its utilization are limited.
Case report: We report the case of a patient who sustained a penetrating cardiac injury grade V AAST-OIS and presented postoperative massive coagulopathic bleeding, arrested by the administration of platelet pools and NovoSeven.
Discussion: This report represents our initial experience and the very first case of successful use of NovoSeven for the treatment of traumatic coagulopathic hemorrhage at the Central Military Hospital in Mexico City. A further prospective trial justifying its use in our institution is warranted.